Pure Global

Creatine Kinase-MB - India CDSCO Medical Device Registration

Creatine Kinase-MB is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000171_9343845239eaebeeeecae874a361bc38_b2979d4bd148582f625aa5e837bffc95. This device is marketed under the brand name CLIA. The license holder is Star Biomed Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Creatine Kinase-MB
UID: IMP/IVD/2023/000171_9343845239eaebeeeecae874a361bc38_b2979d4bd148582f625aa5e837bffc95

Brand Name

CLIA

License Holder

Star Biomed Pvt. Ltd.

Device Class

Class B

Approving Authority

CDSCO

Product Information

Creatine Kinase-MB (CLIA) is a chemiluminescence immunoassay test for the quantitative measurement of circulating Creatine Kinase MB (CLIA) in human serum, plasma and whole blood, which is intended as an aid to diagnosis of myocardial tissue injury and myocardial infarction

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing